THC Tag

21 Jun

Posted at 21:40h in Cannabis

Cannabis Notice: Cannabis laws and regulations vary by country, state, and territory. Cannabis use is intended for adults only and is illegal in many jurisdictions. This article is for educational purposes only and does not constitute medical advice. Cannabis products discussed here are not endorsed by MedicalResearch.com or Eminent Domains Inc. The effects of cannabis vary by individual, and some people may experience adverse reactions. Always consult a qualified healthcare provider before using cannabis, particularly if you have a medical condition, are pregnant or breastfeeding, or are taking prescription medications. Do not use cannabis and drive or operate heavy machinery. Keep cannabis products out of reach of children and pets.

Understanding-Cannabis-Types-and-Their-Differences

Cannabis is a plant that has gained a lot of attention in recent years. You might have heard friends or adults talk about it, but do you really understand what it is? Cannabis comes in many different types, each with its own unique effects and uses. Learning about these cannabis types can help you understand why people use them and how they can affect our bodies and minds.

What Is Cannabis?

Cannabis is a flowering plant that has been used for thousands of years. It contains special compounds called cannabinoids, which can affect the human body in various ways. Two of the most well-known cannabinoids are THC (tetrahydrocannabinol) and CBD (cannabidiol). THC is the compound that produces the feeling of being "high," while CBD is known for its calming effects without producing intoxication.

If you're interested in learning more about cannabis and possibly trying it out, you can visit https://gooddayfarmdispensary.com/dispensaries/ for information about local dispensaries and the various options they offer. Knowledge is key to making informed choices for your personal experience.

12 Jun

Posted at 21:16h in Author Interviews, Cancer Research, Cannabis

Editor's Note: Cannabis laws and regulations vary by country, state, and territory. This interview is for educational purposes only. Cannabis products discussed here are not endorsed by MedicalResearch.com. Patients should consult their oncologist or healthcare provider before using any cannabis or cannabinoid product, particularly during cancer treatment. Cannabis products should not be used while driving, by children, if pregnant, nursing or planning to become pregnant or mixed with other substances that can affect cognition. Cannabis products may also be contraindicated in other medical conditions or situations.

cannabis-and-cancer-posterMedicalResearch.com Interview with: Raphael E. Cuomo, PhD Associate Professor University of California, San Diego Developer and Host, Cannabis and Cancer (Apple TV Documentary)  
MedicalResearch.com: What is the background for this documentary? What are the primary components of cannabis plants? Response: I created Cannabis and Cancer because cannabis is now widely discussed by patients, clinicians, policymakers, and the general public, but there is still a lot of confusion about what the science actually says. Much of the public conversation treats cannabis as either broadly harmful or broadly beneficial. The reality is more complex. The documentary is meant to separate questions that are often conflated: whether cannabis exposure may influence the risk of developing cancer, whether cannabis use may affect cancer treatment or symptoms, and whether it may influence survival after a cancer diagnosis. These are very different scientific questions, and each one requires a different type of evidence. Cannabis plants contain many biologically active compounds. The most widely discussed are cannabinoids, especially THC and CBD. THC is the main intoxicating compound and is responsible for many of the psychoactive effects. CBD is not intoxicating in the same way, but it still has biological effects. Cannabis also contains other cannabinoids, terpenes, flavonoids, and plant compounds that may influence how different products affect the body.

27 Apr

Posted at 19:27h in Cannabis
[caption id="attachment_73447" align="alignleft" width="142"]Edward Liu, MDGeisinger College of Health Sciences Scranton, PA 18509 Dr. Edward Liu[/caption] MedicalResearch.com Interview with: Edward Liu, MD Geisinger College of Health Sciences Scranton, PA 18509 Medicalresearch.com: What is the background for this study? Response: Prescription drugs have high levels of uniformity that plant-based products cannot achieve.  Given the liberalization of state-laws regarding medical marijuana1 over the past three-decades and increasing evidence of evidence of cannabis for conditions like chronic pain,2 we were interested in the use of the prescription formulation of delta(Δ)9-tetrahydrocannabinol (THC).  A prior pharmacoepidemiology report found that prescription THC (dronabinol) to Medicaid patients decreased from 2016 to 2020. There were also pronounced state-level disparities in prescribing with a 130-fold difference when correcting for population between the highest and lowest states. There was no research on this topic among Medicare patients. To address this gap, we obtained prescription numbers nationally and at a state level from 2014 to 2019 for Medicare Part D patients.

25 Mar

Posted at 18:32h in Cannabis
Editor’ note:  Cannabis and THCA/HEMP/ CBD products should have an active ingredient list on the container and have a Certificate of Analysis (COA). Discuss your use of THC, Cannabis or CBD products with your health care provider. Dosing of Cannabis products is variable, especially since they are not FDA regulated. Cannabis/CBD may interfere with other medications and should not be used in individuals with certain health conditions, including liver issues. CBD skin care products can be absorbed through the skin and have similar effects. Do not use Cannabis products including edibles, drinks and CBD if you are pregnant, nursing or may become pregnant. Do not use cannabis products if driving or operating difficult or dangerous machinery. Children should not be exposed to cannabis or CBD products.l MedicalResearch.com Interview with: [caption id="attachment_72930" align="alignleft" width="200"]Meagan Robichaud, PhD, MPHPost-Doctoral Associate Center for Rapid Surveillance of Tobacco Rutgers Institute for Nicotine & Tobacco Studies Meagan Robichaud, Ph.D.[/caption] Meagan Robichaud, PhD, MPH Post-Doctoral Associate Center for Rapid Surveillance of Tobacco Rutgers Institute for Nicotine & Tobacco Studies MedicalResearch.com: What is delta-8 THC? Response: To understand delta-8 THC, it’s first important to understand the primary components of cannabis: THC (tetrahydrocannabinol) and CBD (cannabidiol). THC—typically referring to delta-9 THC—is the primary intoxicating substance in cannabis—it’s what makes consumers feel “high.” CBD is also abundant in cannabis but is non-intoxicating. Delta-8 THC is an isomer of delta-9 THC—meaning it has the same chemical formula as delta-9 THC but with a slightly different arrangement of atoms. While early research suggest that delta-8 THC is less potent than delta-9 THC, delta-8 THC is still an intoxicating substance. Delta-8 THC naturally exists in very small amounts in cannabis plants but can be synthesized from CBD.

03 Jun

Posted at 11:00h in Cannabis

Discuss your use of Cannabis, THC or CBD products with your health care provider.  Do not use Cannabis products including edibles, THC  and CBD if you are pregnant, nursing or may become pregnant. Do not use cannabis products if driving or operating difficult or dangerous machinery. Children should not be exposed to cannabis products

5 Things You Must Know Before Buying THC Drinks

 

THC drinks, the new vibe taking the beverage industry by storm. More partygoers and drinkers are embracing this new sip with zeal. It seems nothing beats the relaxing, social buzz that THC drinks offer. Of course, without having to worry about a punishing headache or  nasty hangovers the day after.

However, not all THC drinks are created equal. That means one thing. Diving in without the right knowledge can lead to a less-than-pleasant experience. What exactly should you know about THC drinks before taking a sip? That’s what this post is all about.

Here are five essential things you must know before buying THC drinks:.

12 Sep

Posted at 09:17h in Cannabis
Editor's note: Please remember the products described below are not FDA tested or approved. The use of edibles can cause unpredictable and potentially serious side effects, including addiction. No cannabinoids in any form should be used while pregnant, nursing or planning to become pregnant. Be sure to avoid driving or any activity which requires mental alertness. It is also important to recognized that these products are not legal in all jurisdictions.  As more people explore the benefits of cannabis, THC edibles have become an increasingly popular way to experience its effects. For beginners, however, edibles can be a little intimidating due to their differences from smoking or vaping cannabis. This guide aims to break down what you need to know about THC edibles, from how they work in the body to tips on choosing safe and reputable products.

How THC Edibles Differ from Smoking or Vaping

When you consume THC through smoking or vaping, it enters your bloodstream quickly via your lungs, leading to effects within minutes. This rapid onset allows users to better control their dose and understand their tolerance more quickly. However, smoking or vaping comes with potential risks to the respiratory system, especially with long-term use. THC edibles, on the other hand, take a different route through the body. When you eat an edible, the THC is absorbed through your digestive system and processed by the liver, which converts it into 11-Hydroxy-THC. This metabolite is known to produce stronger and longer-lasting effects compared to the THC that enters the bloodstream through smoking. However, it also takes longer for these effects to kick in—usually between 30 minutes to two hours. For this reason, beginners should exercise patience and avoid taking additional doses too soon, as it’s easy to overconsume without realizing it.

03 Jul

Posted at 20:10h in Cannabis, Technology
[caption id="attachment_62227" align="alignleft" width="200"]TRE-pens-cbd Pixabay[/caption] In recent times, the lawn of the marijuana market has undergone a massive change, with one product in particular standing out. These smooth, concealed apparatuses have quickly become popular, capturing both old and new souls. The popularity of THC Pen raises pertinent issues about what makes them so widespread among users than other products in the industry. This text tackles this phenomenon by looking at what is drawing many people to these products, how practical they are, and what kind of customers prefer buying THC pens over all other types in today’s day cannabis market.  

Factors Contributing  To The Success Of  THC Pens

The rise of THC pens: a phenomenon explained

THC pens have become extremely popular due to their ease of use, portability, and discreteness. Unlike traditional methods of smoking cannabis, pens provide a more portable and odorless way to consume the drug, which can appeal to a broader audience than seasoned users. This rise has been blamed on changing societal attitudes towards marijuana as well as its legalization in various regions, thus making it commonplace among many individuals. Moreover, their sleek designs and user-friendly traits have made them accessible even to novices who may fear other ways of administration. Consequently, this has made them dominate the cannabis market, thereby showing a paradigm shift in how cannabis products are consumed and perceived.

08 Mar

Posted at 17:37h in Author Interviews, Cannabis, JAMA, OBGYNE, Pediatrics
MedicalResearch.com Interview with: [caption id="attachment_56867" align="alignleft" width="161"]Erica M. Wymore, MD MPH Assistant Professor, Neonatal- Perinatal Medicine Department of Pediatrics, Section of Neonatology University of Colorado School of Medicine Children's Hospital Colorado Dr. Wymore[/caption] Erica M. Wymore, MD MPH Assistant Professor, Neonatal- Perinatal Medicine Department of Pediatrics, Section of Neonatology University of Colorado School of Medicine Children's Hospital Colorado [caption id="attachment_56868" align="alignleft" width="161"]Maya Bunik, MD, MPH  |  Professor, Pediatrics Medical Director, Child Health Clinic, Primary Care  |  Breastfeeding Management Clinic Adult and Child Consortium for Health Outcomes Research and Delivery Science (ACCORDS) School of Medicine| University of Colorado Anschutz Medical Campus Children's Hospital Colorado Dr. Bunik[/caption] Maya Bunik, MD, MPH  |  Professor, Pediatrics Medical Director, Child Health Clinic, Primary Care  |  Breastfeeding Management Clinic Adult and Child Consortium for Health Outcomes Research and Delivery Science (ACCORDS) School of Medicine| University of Colorado Anschutz Medical Campus Children's Hospital Colorado MedicalResearch.com: What is the background for this study? Response: Marijuana legalization has been increasing in the United States, with increasing consumption of marijuana products. Currently, the American Academy of Pediatrics (AAP), American College of Obstetricians and Gynecologists (ACOG) and Academy of Breastfeeding Medicine (ABM) do not recommend marijuana use during pregnancy or lactation due to concerning though limited data on the effects of perinatal marijuana exposure. As there has been increasing prevalence of women using marijuana during pregnancy due to legalization and perceptions of safety, we sought to determine the duration of THC excretion in breast milk among women who had evidence of marijuana use at delivery and abstained post-partum. 

25 Mar

Posted at 15:21h in Addiction, Author Interviews, Cannabis
MedicalResearch.com Interview with: Ryan J. McLaughlin, PhD Assistant Professor Department of Integrative Physiology & Neuroscience College of Veterinary Medicine Washington State University, Pullman, WA Ryan J. McLaughlin, PhD Assistant Professor Department of Integrative Physiology & Neuroscience College of Veterinary Medicine Washington State University, Pullman, WA MedicalResearch.com: What is the background for this study? Response: The evolving legal landscape concerning the use of cannabis has increased urgency to better understand its effects on the brain and behavior. Animal models are advantageous in this respect; however, researchers traditionally use forced injections of synthetic cannabinoids which fails to capture the complex effects of volitional cannabis consumption. In our study, we developed a novel model of cannabis self-administration using response-contingent delivery of vaporized cannabis extracts containing high concentrations of Δ9 tetrahydrocannabinol (THC) or cannabidiol (CBD).

17 Jan

Posted at 15:54h in Author Interviews, OBGYNE, Pain Research
MedicalResearch.com Interview with: [caption id="attachment_52845" align="alignleft" width="200"]Rafael Maldonado Lopez MD PhD Full professor Departament de Ciències Experimentals i de la Salut Universitat Pompeu Fabra Barcelona Dr. Maldonado Lopez[/caption] Rafael Maldonado Lopez MD PhD Full professor Departament de Ciències Experimentals i de la Salut Universitat Pompeu Fabra Barcelona MedicalResearch.com: What is the background for this study? Response: Endometriosis is a common, chronic and painful disease caused when the endometrium grows outside of the uterine cavity. These growths mainly affect organs in the pelvis causing pain and infertility, symptoms that are often accompanied with anxiety, depression, loss of working ability, and a substantial impact on quality of life. Current treatments include hormonal therapy and surgery, but the effectiveness of these treatments is rather limited, often have important unwanted side effects, and patients usually rely on self-management strategies. Therefore, there is an urgent need for researching new possible therapeutic approaches. 

28 Mar

Posted at 22:06h in Author Interviews, Cancer Research, Cannabis, End of Life Care, NYU/NYMC
MedicalResearch.com Interview with: [caption id="attachment_48264" align="alignleft" width="200"]Arum Kim, MDAssistant professor of Medicine and Rehabilitation MedicineNYU School of MedicineDirector of the Supportive Oncology ProgramPerlmutter Cancer Center Dr. Kim[/caption] Arum Kim, MD Assistant Professor Medicine and Rehabilitation Medicine NYU School of Medicine Director of the Supportive Oncology Program Perlmutter Cancer Center MedicalResearch.com: What is the background for this study?   Response: There is increasing interest in medical marijuana and its applications for patients with cancers. Despite increasing access, little is known regarding doses of cannabinoids - specifically delta-8-tetrahydrocannabinol (delta-8-THC)  and cannabidiol (CBD), methods of drug delivery, and differences in patterns of use between cancer and non-cancer patients.

17 Oct

Posted at 20:25h in Author Interviews, Cannabis, Genetic Research, JAMA, Mental Health Research
MedicalResearch.com Interview with: Dr. Nicole Karcher, PhD Post-doctoral scholar with the NIMH Training in Clinical Sciences fellowship Department of Psychiatry Washington University School of Medicine   MedicalResearch.com: What is the background for this study? What are the main findings? Response: For over fifteen years, researchers have debated the role that cannabis use plays in the development of both psychotic disorders as well as subthreshold psychotic symptoms, such as psychotic-like experiences (PLEs). There is still a lack of consensus regarding the nature of the association between cannabis use and psychosis risk, with some research finding evidence for genetic overlap, while other research finds evidence for potentially causal pathways. The current study examined data from twins and siblings from two different samples, the U.S.-based Human Connectome Project and the Australian Twin Registry, with a total of 4,674 participants. Overall, psychotic-like experiences were associated with three separate cannabis use variables [frequent (≥100 times) use, a Cannabis Use Disorder diagnosis, and current cannabis use]. Furthermore, the current research found evidence for both shared genetic and individual-specific contributions to the association between PLEs and these three cannabis use variables. More specifically, while the association between cannabis use and psychotic-like experiences was largely attributable to shared genetic factors, cannabis users were more likely to endorse PLEs in comparison to the relative who used cannabis less. 

03 Oct

Posted at 12:24h in Author Interviews, Cannabis, Surgical Research
David Plurad, MD Los Angeles Biomedical Research In MedicalResearch.com Interview with: David Plurad, MD Los Angeles Biomedical Research Institute. Medical Research: What are the main findings of the study? Based on a survey of patients with traumatic brain injuries, a group of Los Angeles Biomedical Research Institute researchers found those who tested positive for tetrahydrocannabinol (THC), the active ingredient in marijuana, were more likely to survive than those who tested negative for the illicit substance. We surveyed 446 patients who were admitted to a major urban hospital with traumatic brain injuries between Jan. 1, 2010, and Dec. 31, 2012, who were also tested for the presence of THC in their urine. We found 82 of the patients had THC in their system. Of those, 2.4% died. Of the remaining patients who didn't have THC in their system, 11.5% died. While most - but not all - the deaths in the study can be attributed to the traumatic brain injury itself, it appears that both groups were similarly injured. The similarities in the injuries between the two groups led to the conclusion that testing positive for THC in the system is associated with a decreased mortality in adult patients who have sustained traumatic brain injuries.